U.S. senator calls for GAO probe to protect babies born drug-dependent

Published 03/03/2016, 11:36 AM
© Reuters. Former drug addict Pederson looks at family photos of her baby Avery, on the floor of her home in Devils Lake, North Dakota

By Duff Wilson

NEW YORK (Reuters) - The ranking Democrat on the U.S. Senate subcommittee on children and families wants a congressional watchdog agency to investigate whether states are complying with a federal law meant to protect newborns in drug withdrawal and help their families.

In a letter sent this week to the U.S. Government Accountability Office, Senator Robert Casey of Pennsylvania asked that the probe examine what steps Congress or the Obama Administration could take "to improve compliance and save the lives of vulnerable infants."

The request comes in response to a Reuters investigation in December that identified the preventable deaths of 110 babies whose mothers used opioids during pregnancy and were subsequently sent home to families ill-equipped to care for them.

A 2003 federal law calls on states to require that healthcare workers notify child protection services when a baby is born affected by illegal substance abuse or has symptoms of drug withdrawal. Such reports are not to be used as evidence of abuse, the law says, but rather to help develop a “plan of safe care” for the newborns after they leave the hospital.

Reuters found that no more than nine states and the District of Columbia appear to follow the law. Even so, no state had lost federal funding from failing to abide by the provision. More than 27,000 newborns in the United States were diagnosed with drug withdrawal syndrome in 2013 – five times the number diagnosed with the condition in 2003.

"Reuters' groundbreaking report on the condition of children born with opioid dependencies should be a call to action for all members of Congress," Casey said in a separate statement.

Cathleen Palm, executive director of the Center for Children's Justice, a Pennsylvania non-profit advocacy group, supported Casey's action. 

"By GAO and Congress saying we want states to tangibly tell us what they are doing, it's going to force them to really look at it," Palm said. "It just feels like we're about to get a whole lot more motivated about these babies and their families."

Mark Weber, a spokesman for the U.S. Department of Health and Human Services, which oversees compliance with the law, said the agency will "work with the GAO when an inquiry is made."

© Reuters. Former drug addict Pederson looks at family photos of her baby Avery, on the floor of her home in Devils Lake, North Dakota

The Reuters investigation, “Helpless & Hooked,” can be found at http://reut.rs/1NSc7uC

(Edited by Blake Morrison)

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2025 - Fusion Media Limited. All Rights Reserved.